Overview

Headquartered in Alameda, California, Penumbra, Inc. is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

NYSE: PEN 87.35 +0.30 +0.34%
Volume: 167,435
Pricing delayed 20 minutes April 26, 2017 04:02 PM

SEC Filings

Date Filing Type Filing Description Download
Date April 26, 2017 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date April 25, 2017 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date April 25, 2017 Filing Type Form 3 Filing Description Initial Statement of Beneficial Ownership Download

IR Contact

investors@penumbrainc.com

Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502
USA